Bharat Biotech has not made any official in this regard.
It is up to the health ministry to decide if COVAXIN shots can be given to people even before the third stage trials are over, Kant, head of ICMR’s research management, policy, planning and coordination cell was quoted as saying.
“It has shown safety and efficacy in the phase 1 and 2 trials and in the animal studies – so it is safe but you can’t be 100% sure unless the phase 3 trials are over,” he added.
“There may be some risk, if you are ready to take the risk, you can take the vaccine. If necessary, the government can think of giving the vaccine in an emergency situation,” he was further quoted a saying by The Hindu.